Recent studies reported that a variety of tumor cells highly expressed HLA-E, which allowed them to escape the immune recognition of NK and CD8+ T cells by interactions with inhibitory receptors of the CD94-NKG2 family [44]. The gene discussed is KLRD1; the disease is neoplasm.